 Coronary Artery Disease
"Coronary Artery Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Descriptor ID |
D003324
|
| MeSH Number(s) |
C14.280.647.250.260 C14.907.137.126.339 C14.907.585.250.260
|
| Concept/Terms |
Coronary Artery Disease- Coronary Artery Disease
- Artery Disease, Coronary
- Artery Diseases, Coronary
- Coronary Artery Diseases
- Disease, Coronary Artery
- Diseases, Coronary Artery
Coronary Arteriosclerosis- Coronary Arteriosclerosis
- Arterioscleroses, Coronary
- Coronary Arterioscleroses
- Atherosclerosis, Coronary
- Atheroscleroses, Coronary
- Coronary Atheroscleroses
- Coronary Atherosclerosis
- Arteriosclerosis, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Coronary Artery Disease".
Below are MeSH descriptors whose meaning is more specific than "Coronary Artery Disease".
This graph shows the total number of publications written about "Coronary Artery Disease" by people in this website by year, and whether "Coronary Artery Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 0 | 1 | 1 | | 1993 | 1 | 0 | 1 | | 1994 | 1 | 0 | 1 | | 1996 | 3 | 0 | 3 | | 1997 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2001 | 2 | 2 | 4 | | 2002 | 3 | 1 | 4 | | 2003 | 7 | 1 | 8 | | 2004 | 8 | 2 | 10 | | 2005 | 6 | 1 | 7 | | 2006 | 3 | 0 | 3 | | 2007 | 8 | 1 | 9 | | 2008 | 6 | 2 | 8 | | 2009 | 13 | 3 | 16 | | 2010 | 13 | 3 | 16 | | 2011 | 8 | 2 | 10 | | 2012 | 9 | 2 | 11 | | 2013 | 12 | 3 | 15 | | 2014 | 16 | 2 | 18 | | 2015 | 17 | 7 | 24 | | 2016 | 12 | 3 | 15 | | 2017 | 20 | 0 | 20 | | 2018 | 17 | 5 | 22 | | 2019 | 23 | 4 | 27 | | 2020 | 10 | 2 | 12 | | 2021 | 19 | 0 | 19 | | 2022 | 7 | 0 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Coronary Artery Disease" by people in Profiles.
-
Kini V, Parks M, Liu W, Waldo SW, Ho PM, Bradley SM, Hess PL. Patient Symptoms and Stress Testing After Elective Percutaneous Coronary Intervention in the Veterans Affairs Health Care System. JAMA Netw Open. 2022 06 01; 5(6):e2217704.
-
Gordin D, Bjornstad P, van Raalte DH. Lipids in CKD: What do we actually know? Atherosclerosis. 2022 06; 350:97-99.
-
Jovanovich A, Cai X, Frazier R, Bundy JD, He J, Rao P, Lora C, Dobre M, Go A, Shafi T, Feldman HI, Rhee EP, Miyazaki M, Isakova T, Chonchol M. Deoxycholic Acid and Coronary Artery Calcification in the Chronic Renal Insufficiency Cohort. J Am Heart Assoc. 2022 04 05; 11(7):e022891.
-
Friedman RSC, Carpenter DM, Shaver JM, McDermott SC, Voelkel J. Telemedicine Familiarity and Post-Disaster Utilization of Emergency and Hospital Services for Ambulatory Care Sensitive Conditions. Am J Prev Med. 2022 07; 63(1):e1-e9.
-
Grover DS, Kahook MY, Seibold LK, Singh IP, Ansari H, Butler MR, Smith OU, Sawhney GK, Van Tassel SH, Dorairaj S. Clinical Outcomes of Ahmed ClearPath Implantation in Glaucomatous Eyes: A Novel Valveless Glaucoma Drainage Device. J Glaucoma. 2022 May 01; 31(5):335-339.
-
Vallurupalli S, Hess E, Plomondon ME, Park K, Waldo SW, Agarwal S, Uretsky BF. Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program. Catheter Cardiovasc Interv. 2022 04; 99(5):1491-1497.
-
Waldo SW, Glorioso TJ, Barón AE, Doll JA, Plomondon ME, Ho PM. Transitions of Care Among Patients Undergoing Percutaneous Coronary Intervention for Stable Angina: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Program. J Am Heart Assoc. 2022 02 15; 11(4):e024598.
-
Doll JA, O'Donnell CI, Plomondon ME, Waldo SW. Contemporary Clinical and Coronary Anatomic Risk Model for 30-Day Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2021 12; 14(12):e010863.
-
Ruff CT, Koren MJ, Grimsby J, Rosenbaum AI, Tu X, Karathanasis SK, Falloon J, Hsia J, Guan Y, Conway J, Tsai LF, Hummer BT, Hirshberg B, Kuder JF, Murphy SA, George RT, Sabatine MS. LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2021 12; 41(12):3005-3014.
-
Kotla S, Zhang A, Imanishi M, Ko KA, Lin SH, Gi YJ, Moczygemba M, Isgandarova S, Schadler KL, Chung C, Milgrom SA, Banchs J, Yusuf SW, Amaya DN, Guo H, Thomas TN, Shen YH, Deswal A, Herrmann J, Kleinerman ES, Entman ML, Cooke JP, Schifitto G, Maggirwar SB, McBeath E, Gupte AA, Krishnan S, Patel ZS, Yoon Y, Burks JK, Fujiwara K, Brookes PS, Le NT, Hamilton DJ, Abe JI. Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiation. Redox Biol. 2021 11; 47:102132.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|